AstraZeneca PLC (AZN)
68.36
-0.17
(-0.25%)
USD |
NASDAQ |
Apr 18, 16:00
68.36
0.00 (0.00%)
After-Hours: 18:03
AstraZeneca Total Long Term Debt (Quarterly): 27.49B for Dec. 31, 2023
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 27.49B |
September 30, 2023 | 27.60B |
June 30, 2023 | 28.88B |
March 31, 2023 | 30.54B |
December 31, 2022 | 28.28B |
September 30, 2022 | 28.42B |
June 30, 2022 | 28.62B |
March 31, 2022 | 30.15B |
December 31, 2021 | 29.79B |
September 30, 2021 | 30.95B |
June 30, 2021 | 26.80B |
March 31, 2021 | 19.45B |
December 31, 2020 | 19.70B |
September 30, 2020 | 21.67B |
June 30, 2020 | 19.11B |
March 31, 2020 | 17.92B |
December 31, 2019 | 17.55B |
September 30, 2019 | 17.45B |
June 30, 2019 | 18.98B |
March 31, 2019 | 20.86B |
December 31, 2018 | 19.11B |
September 30, 2018 | 20.91B |
June 30, 2018 | 19.67B |
March 31, 2018 | 19.85B |
December 31, 2017 | 17.80B |
Date | Value |
---|---|
September 30, 2017 | 17.85B |
June 30, 2017 | 19.72B |
March 31, 2017 | 17.32B |
December 31, 2016 | 16.72B |
September 30, 2016 | 17.68B |
June 30, 2016 | 17.48B |
March 31, 2016 | 16.21B |
December 31, 2015 | 14.96B |
September 30, 2015 | 10.95B |
June 30, 2015 | 11.01B |
March 31, 2015 | 10.46B |
December 31, 2014 | 10.74B |
September 30, 2014 | 9.926B |
June 30, 2014 | 9.961B |
March 31, 2014 | 10.23B |
December 31, 2013 | 10.27B |
September 30, 2013 | 10.18B |
June 30, 2013 | 10.29B |
March 31, 2013 | 10.21B |
December 31, 2012 | 10.23B |
September 30, 2012 | 10.91B |
June 30, 2012 | 9.318B |
March 31, 2012 | 9.383B |
December 31, 2011 | 9.328B |
September 30, 2011 | 9.449B |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
17.45B
Minimum
Sep 2019
30.95B
Maximum
Sep 2021
24.70B
Average
27.49B
Median
Dec 2023
Total Long Term Debt (Quarterly) Benchmarks
GSK PLC | 21.42B |
Amgen Inc | 64.61B |
Gilead Sciences Inc | 24.99B |
Viking Therapeutics Inc | -- |
Fusion Pharmaceuticals Inc | -- |